The Impact of Taurine on Obesity-Induced Diabetes Mellitus: Mechanisms Underlying Its Effect
This review explores the potential benefits of taurine in ameliorating the metabolic disorders of obesity and type 2 diabetes (T2D), highlighting the factors that bridge these associations. Relevant articles and studies were reviewed to conduct a comprehensive analysis of the relationship between ob...
Saved in:
| Published in | Endocrinology and metabolism (Seoul) Vol. 38; no. 5; pp. 482 - 492 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
Korean Endocrine Society
01.10.2023
대한내분비학회 |
| Subjects | |
| Online Access | Get full text |
| ISSN | 2093-596X 2093-5978 2093-5978 |
| DOI | 10.3803/EnM.2023.1776 |
Cover
| Abstract | This review explores the potential benefits of taurine in ameliorating the metabolic disorders of obesity and type 2 diabetes (T2D), highlighting the factors that bridge these associations. Relevant articles and studies were reviewed to conduct a comprehensive analysis of the relationship between obesity and the development of T2D and the effect of taurine on those conditions. The loss of normal β-cell function and development of T2D are associated with obesity-derived insulin resistance. The occurrence of diabetes has been linked to the low bioavailability of taurine, which plays critical roles in normal β-cell function, anti-oxidation, and anti-inflammation. The relationships among obesity, insulin resistance, β-cell dysfunction, and T2D are complex and intertwined. Taurine may play a role in ameliorating these metabolic disorders through different pathways, but further research is needed to fully understand its effects and potential as a therapeutic intervention. |
|---|---|
| AbstractList | This review explores the potential benefits of taurine in ameliorating the metabolic disorders of obesity and type 2 diabetes (T2D), highlighting the factors that bridge these associations. Relevant articles and studies were reviewed to conduct a comprehensive analysis of the relationship between obesity and the development of T2D and the effect of taurine on those conditions. The loss of normal β-cell function and development of T2D are associated with obesity-derived insulin resistance. The occurrence of diabetes has been linked to the low bioavailability of taurine, which plays critical roles in normal β-cell function, anti-oxidation, and anti-inflammation. The relationships among obesity, insulin resistance, β-cell dysfunction, and T2D are complex and intertwined. Taurine may play a role in ameliorating these metabolic disorders through different pathways, but further research is needed to fully understand its effects and potential as a therapeutic intervention.This review explores the potential benefits of taurine in ameliorating the metabolic disorders of obesity and type 2 diabetes (T2D), highlighting the factors that bridge these associations. Relevant articles and studies were reviewed to conduct a comprehensive analysis of the relationship between obesity and the development of T2D and the effect of taurine on those conditions. The loss of normal β-cell function and development of T2D are associated with obesity-derived insulin resistance. The occurrence of diabetes has been linked to the low bioavailability of taurine, which plays critical roles in normal β-cell function, anti-oxidation, and anti-inflammation. The relationships among obesity, insulin resistance, β-cell dysfunction, and T2D are complex and intertwined. Taurine may play a role in ameliorating these metabolic disorders through different pathways, but further research is needed to fully understand its effects and potential as a therapeutic intervention. This review explores the potential benefits of taurine in ameliorating the metabolic disorders of obesity and type 2 diabetes (T2D), highlighting the factors that bridge these associations. Relevant articles and studies were reviewed to conduct a comprehensive analysis of the relationship between obesity and the development of T2D and the effect of taurine on those conditions. The loss of normal β-cell function and development of T2D are associated with obesity-derived insulin resistance. The occurrence of diabetes has been linked to the low bioavailability of taurine, which plays critical roles in normal β-cell function, anti-oxidation, and anti-inflammation. The relationships among obesity, insulin resistance, β-cell dysfunction, and T2D are complex and intertwined. Taurine may play a role in ameliorating these metabolic disorders through different pathways, but further research is needed to fully understand its effects and potential as a therapeutic intervention. KCI Citation Count: 0 This review explores the potential benefits of taurine in ameliorating the metabolic disorders of obesity and type 2 diabetes (T2D), highlighting the factors that bridge these associations. Relevant articles and studies were reviewed to conduct a comprehensive analysis of the relationship between obesity and the development of T2D and the effect of taurine on those conditions. The loss of normal β-cell function and development of T2D are associated with obesity-derived insulin resistance. The occurrence of diabetes has been linked to the low bioavailability of taurine, which plays critical roles in normal β-cell function, anti-oxidation, and anti-inflammation. The relationships among obesity, insulin resistance, β-cell dysfunction, and T2D are complex and intertwined. Taurine may play a role in ameliorating these metabolic disorders through different pathways, but further research is needed to fully understand its effects and potential as a therapeutic intervention. |
| Author | Ahmed, Kainat Choi, Ha-Neul Yim, Jung-Eun |
| Author_xml | – sequence: 1 givenname: Kainat orcidid: 0000-0002-5603-8935 surname: Ahmed fullname: Ahmed, Kainat – sequence: 2 givenname: Ha-Neul surname: Choi fullname: Choi, Ha-Neul – sequence: 3 givenname: Jung-Eun orcidid: 0000-0001-8344-1386 surname: Yim fullname: Yim, Jung-Eun |
| BackLink | https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003010622$$DAccess content in National Research Foundation of Korea (NRF) |
| BookMark | eNptkt1rFDEUxQep2Fr76Ps8ijBrPiaZjC9S6qoDLQXZgg9CyCQ3u2lnM9skI-x_b2a3ChXzci_JOT8O4bwuTvzooSjeYrSgAtEPS3-zIIjQBW4a_qI4I6ilFWsbcfJ35z9Oi4sY71E-QtSY4FfFKW1EzRHjZ8XP1QbKbrtTOpWjLVdqCs5DOfrytofo0r7qvJk0mPKzUz0kiOUNDINLU_yYN71R3sVtLO-8gTDsnV-XXYrl0lrQ6U3x0qohwsXTPC_uvixXV9-q69uv3dXldaVrzlMlrOmhIchSzLjASCBU65ZijqzVgrU1QYKAwsxopDjCjDCA3miW5b3Bip4X749cH6x80E6Oyh3mepQPQV5-X3USI0owqVkWd0exGdW93AW3VWF_cBwuxrCWKiSnB5AMCctNg3FDeM1V3wpte0VFbTQX0JPM-nRk7aZ-C0aDT0ENz6DPX7zb5FC_chqOacPbTHj3RAjj4wQxya2LOv-w8jBOURLRCNKims3B6VGqwxhjACu1Syq5cUa7ITPlXAqZSyHnUsi5FNlV_eP6k-7_-t_D27fY |
| CitedBy_id | crossref_primary_10_3390_foods13233943 crossref_primary_10_4239_wjd_v16_i1_100066 crossref_primary_10_3390_antiox13030302 crossref_primary_10_3390_metabo14100518 |
| Cites_doi | 10.1111/j.2040-1124.2010.00072.x 10.1172/jci5656 10.1074/jbc.ra119.009936 10.1017/s0022029905001299 10.1186/s40104-022-00675-6 10.1152/physrev.00063.2017 10.1007/s00726-015-1995-0 10.1038/s41392-022-01073-0 10.1007/s00726-011-0962-7 10.1196/annals.1395.061 10.1016/j.fct.2009.04.030 10.1371/journal.pone.0076961 10.1002/dmrr.959 10.1007/s00726-015-2110-2 10.1186/1423-0127-17-s1-s11 10.1111/liv.12291 10.1017/s0007114510001820 10.1055/a-1263-0898 10.1002/dmrr.229 10.1007/978-3-319-48382-5_18 10.21037/atm.2020.02.184 10.14814/phy2.14607 10.1007/s00394-015-1114-8 10.1038/nature05482 10.1038/sj.ejcn.1601955 10.1039/c5fo01295c 10.1016/j.jnutbio.2014.10.015 10.1016/j.redox.2019.101223 10.1002/mnfr.201800536 10.2337/db20-0377 10.1007/978-1-4615-0077-3_13 10.3390/nu14061292 10.1007/s00726-012-1434-4 10.1017/s0954422415000098 10.1002/jlb.54.2.119 10.1016/j.pathophys.2012.05.001 10.1016/j.toxicon.2022.06.003 10.1016/j.bcp.2003.11.003 10.1007/s00726-013-1545-6 10.1016/j.trsl.2015.08.011 10.1007/978-1-4614-6093-0_5 10.1076/apab.109.1.90.4287 10.1038/s41574-020-0355-7 10.1002/mnfr.201200345 10.1016/j.lfs.2017.08.008 10.1002/oby.22674 10.1038/s41419-018-1004-0 10.1016/j.ecl.2008.07.002 10.1016/j.diabres.2010.08.020 10.1002/mnfr.201300150 10.1016/0006-2952(84)90204-1 10.1016/s0165-2478(01)00291-7 10.3390/ijms22105159 10.4066/amj.2014.1979 10.1007/s00726-018-2659-7 10.1016/j.metabol.2018.09.005 10.1016/j.jnutbio.2008.05.008 10.54634/2090-9101.1022 10.1152/ajpendo.00355.2002 10.7570/jomes21088 10.1159/000048587 10.1007/s13105-019-00677-5 |
| ContentType | Journal Article |
| Copyright | Copyright © 2023 Korean Endocrine Society 2023 |
| Copyright_xml | – notice: Copyright © 2023 Korean Endocrine Society 2023 |
| DBID | AAYXX CITATION 7X8 5PM DOA ACYCR |
| DOI | 10.3803/EnM.2023.1776 |
| DatabaseName | CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals Korean Citation Index |
| DatabaseTitle | CrossRef MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic CrossRef |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 2093-5978 |
| EndPage | 492 |
| ExternalDocumentID | oai_kci_go_kr_ARTI_10321245 oai_doaj_org_article_508f6d71172646ab98cfba384dc68eb2 PMC10613769 10_3803_EnM_2023_1776 |
| GroupedDBID | 5-W 53G 5VS 8JR 8XY AAYXX ABDBF ACUHS ADBBV ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EF. GROUPED_DOAJ HYE HZB KQ8 M48 OK1 PGMZT RPM 7X8 5PM ACYCR ADRAZ IPNFZ RIG |
| ID | FETCH-LOGICAL-c466t-8fdbe720f31568108004c93160ffc85942082ea15dc0a601525eebdc5156bd1a3 |
| IEDL.DBID | DOA |
| ISSN | 2093-596X 2093-5978 |
| IngestDate | Fri Jan 12 03:13:24 EST 2024 Wed Aug 27 01:32:33 EDT 2025 Thu Aug 21 18:36:52 EDT 2025 Thu Jul 10 18:52:39 EDT 2025 Tue Jul 01 01:37:50 EDT 2025 Thu Apr 24 23:11:00 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Language | English |
| License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c466t-8fdbe720f31568108004c93160ffc85942082ea15dc0a601525eebdc5156bd1a3 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
| ORCID | 0000-0002-5603-8935 0000-0001-8344-1386 |
| OpenAccessLink | https://doaj.org/article/508f6d71172646ab98cfba384dc68eb2 |
| PMID | 37846056 |
| PQID | 2878290455 |
| PQPubID | 23479 |
| PageCount | 11 |
| ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_10321245 doaj_primary_oai_doaj_org_article_508f6d71172646ab98cfba384dc68eb2 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10613769 proquest_miscellaneous_2878290455 crossref_citationtrail_10_3803_EnM_2023_1776 crossref_primary_10_3803_EnM_2023_1776 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2023-10-01 |
| PublicationDateYYYYMMDD | 2023-10-01 |
| PublicationDate_xml | – month: 10 year: 2023 text: 2023-10-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationTitle | Endocrinology and metabolism (Seoul) |
| PublicationYear | 2023 |
| Publisher | Korean Endocrine Society 대한내분비학회 |
| Publisher_xml | – name: Korean Endocrine Society – name: 대한내분비학회 |
| References | ref13 ref57 ref12 ref56 ref15 ref59 ref14 ref58 ref53 ref52 ref11 ref55 ref10 ref54 ref16 ref19 ref18 Jong (ref50) 2011 ref51 ref45 ref48 ref47 ref42 ref41 Suba (ref21) 2020 ref44 ref43 ref49 ref8 ref7 ref9 ref3 ref6 ref5 ref40 ref35 Yoon (ref17) 2006 ref34 ref37 ref36 ref31 ref30 ref33 ref32 ref2 Abdul-Ghani (ref25) 2006 ref1 ref39 ref38 Xiao (ref4) 2011 Oprescu (ref66) 2007 Han (ref46) 2004 ref24 ref68 ref23 ref67 ref26 ref69 ref20 ref64 ref63 ref22 ref65 ref28 ref27 ref29 ref60 ref62 ref61 |
| References_xml | – ident: ref27 doi: 10.1111/j.2040-1124.2010.00072.x – ident: ref28 doi: 10.1172/jci5656 – start-page: 2927 volume-title: Free fatty acid-induced reduction in glucosestimulated insulin secretion: evidence for a role of oxidative stress in vitro and in vivo year: 2007 ident: ref66 – ident: ref34 doi: 10.1074/jbc.ra119.009936 – ident: ref14 doi: 10.1017/s0022029905001299 – volume-title: Longitudinal imaging of pancreatic islets transplanted into the anterior chamber of the eye [dissertation] year: 2020 ident: ref21 – ident: ref5 doi: 10.1186/s40104-022-00675-6 – ident: ref29 doi: 10.1152/physrev.00063.2017 – ident: ref48 doi: 10.1007/s00726-015-1995-0 – ident: ref20 doi: 10.1038/s41392-022-01073-0 – start-page: 1130 volume-title: Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose year: 2006 ident: ref25 – ident: ref54 doi: 10.1007/s00726-011-0962-7 – ident: ref57 doi: 10.1196/annals.1395.061 – ident: ref65 doi: 10.1016/j.fct.2009.04.030 – ident: ref13 doi: 10.1371/journal.pone.0076961 – ident: ref68 doi: 10.1002/dmrr.959 – ident: ref60 doi: 10.1007/s00726-015-2110-2 – ident: ref61 doi: 10.1186/1423-0127-17-s1-s11 – ident: ref42 doi: 10.1111/liv.12291 – ident: ref67 doi: 10.1017/s0007114510001820 – ident: ref31 doi: 10.1055/a-1263-0898 – ident: ref11 doi: 10.1002/dmrr.229 – ident: ref24 doi: 10.1007/978-3-319-48382-5_18 – ident: ref19 doi: 10.21037/atm.2020.02.184 – ident: ref30 doi: 10.14814/phy2.14607 – ident: ref35 doi: 10.1007/s00394-015-1114-8 – ident: ref3 doi: 10.1038/nature05482 – ident: ref9 doi: 10.1038/sj.ejcn.1601955 – ident: ref12 doi: 10.1039/c5fo01295c – ident: ref64 doi: 10.1016/j.jnutbio.2014.10.015 – ident: ref6 doi: 10.1016/j.redox.2019.101223 – ident: ref33 doi: 10.1002/mnfr.201800536 – ident: ref22 doi: 10.2337/db20-0377 – ident: ref8 doi: 10.1007/978-1-4615-0077-3_13 – ident: ref39 doi: 10.3390/nu14061292 – ident: ref10 doi: 10.1007/s00726-012-1434-4 – ident: ref15 doi: 10.1017/s0954422415000098 – ident: ref55 doi: 10.1002/jlb.54.2.119 – ident: ref49 doi: 10.1016/j.pathophys.2012.05.001 – ident: ref47 doi: 10.1016/j.toxicon.2022.06.003 – ident: ref53 doi: 10.1016/j.bcp.2003.11.003 – ident: ref59 doi: 10.1007/s00726-013-1545-6 – ident: ref62 doi: 10.1016/j.trsl.2015.08.011 – ident: ref43 doi: 10.1007/978-1-4614-6093-0_5 – ident: ref58 doi: 10.1076/apab.109.1.90.4287 – ident: ref26 doi: 10.1038/s41574-020-0355-7 – ident: ref38 doi: 10.1002/mnfr.201200345 – ident: ref63 doi: 10.1016/j.lfs.2017.08.008 – start-page: 125 volume-title: Role of mitochondrial permeability transition in taurine deficiency-induced apoptosis year: 2011 ident: ref50 – ident: ref18 doi: 10.1002/oby.22674 – ident: ref44 doi: 10.1038/s41419-018-1004-0 – ident: ref23 doi: 10.1016/j.ecl.2008.07.002 – ident: ref51 doi: 10.1016/j.diabres.2010.08.020 – ident: ref36 doi: 10.1002/mnfr.201300150 – ident: ref52 doi: 10.1016/0006-2952(84)90204-1 – ident: ref56 doi: 10.1016/s0165-2478(01)00291-7 – ident: ref16 doi: 10.3390/ijms22105159 – ident: ref2 doi: 10.4066/amj.2014.1979 – ident: ref32 doi: 10.1007/s00726-018-2659-7 – ident: ref1 doi: 10.1016/j.metabol.2018.09.005 – start-page: E1008 volume-title: Taurine increases glucose sensitivity of UCP2-overexpressing beta-cells by ameliorating mitochondrial metabolism year: 2004 ident: ref46 – ident: ref45 doi: 10.1016/j.jnutbio.2008.05.008 – start-page: 918 volume-title: Sodium phenylbutyrate, a drug with known capacity to reduce endoplasmic reticulum stress, partially alleviates lipid-induced insulin resistance and beta-cell dysfunction in humans year: 2011 ident: ref4 – start-page: 2562 volume-title: Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha year: 2006 ident: ref17 – ident: ref7 doi: 10.54634/2090-9101.1022 – ident: ref69 doi: 10.1152/ajpendo.00355.2002 – ident: ref40 doi: 10.7570/jomes21088 – ident: ref41 doi: 10.1159/000048587 – ident: ref37 doi: 10.1007/s13105-019-00677-5 |
| SSID | ssj0000884121 |
| Score | 2.3162537 |
| SecondaryResourceType | review_article |
| Snippet | This review explores the potential benefits of taurine in ameliorating the metabolic disorders of obesity and type 2 diabetes (T2D), highlighting the factors... |
| SourceID | nrf doaj pubmedcentral proquest crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
| StartPage | 482 |
| SubjectTerms | beta-cell dysfunction diabetes complications inflammation obesity Review taurine 내과학 |
| SummonAdditionalLinks | – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nj5RAEO3oevFi1qgRXU0bjScZaegvTIxRs5sdk_G0k8zBpAP9sU52BAUm0X9vVcOuEvXmCQINgapu6j266xUhz5TnQvi8wh9VLuVe5WlVuyz1LAuKiSCyGhOcVx_l6Zp_2IjNL0mhyYD9X6kd1pNad7vF928_3sCAf42MU2fFy-NmtcAq4AumlLxObkBQksjDVhPSjx9lrTmLWVg5cPhUlHIzKm7-eYdZhIpC_hB3mi7MMOh8BeVvIenkkNyasCR9Ozr_NrnmmzvkEzieLmPuI20DPUPZoMbTtqFTDYAUq3VY7-i0GKanKxTlHPb9K9jDROBt_6WnsSDSDpOg6HLo6ahyfJesT47P3p-mUwmF1HIph1QHV4P9s1CwqDwG8JDbsmAyC8FqUeLkeu4rJpzNKuBmIhfe184CypG1Y1Vxjxw0bePvE1p6gFJcVZr7givttS6ZLl2li0LltVQJeXFpNmMnfXEsc7EzwDPQygasbNDKBq2ckOdXzb-Owhr_avgOfXDVCPWw44G2OzfT8DIAM4N0igEck1xWdaltqKtCc2el9nWekKfgQXNht_F63J635qIzwBqWBkUFAeeIhDy59LCBUYZTJ1Xj231vgFfijDP064TometnzzU_02w_R71uZN3wHS8f_I83eUhuomnG9YRH5GDo9v4R4KKhfhx7_E8-fgmN priority: 102 providerName: Scholars Portal |
| Title | The Impact of Taurine on Obesity-Induced Diabetes Mellitus: Mechanisms Underlying Its Effect |
| URI | https://www.proquest.com/docview/2878290455 https://pubmed.ncbi.nlm.nih.gov/PMC10613769 https://doaj.org/article/508f6d71172646ab98cfba384dc68eb2 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003010622 |
| Volume | 38 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | Endocrinology and Metabolism, 2023, 38(5), , pp.482-492 |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT1wQCBDhJSMQJ9LG8SNObwW16iItp1baA5Ll-AGrFgdtsv-fGSetNgfEhUsSxY7kfDOxZ-KZbwj50AQhZagt_qjypQhNXdrOV2VgVWyYjLLqMMF5_U1dXouvG7k5KPWFMWETPfAE3AkYEFH5hsFCq4SyXatd7CzXwjulwS3E2bdqqwNnKs_BWguWk66gkZeyVZuJYJPrip-cp_Uxlg0_Zg1yjRwsSJm3H5aZtIsLk3MZMHmwAl08Jo9m05GeTUN-Qh6E9JR8BznTVU51pH2kV8gSlALtE50p_0sszuGCp3Psy0DXyME57odTuMK83-3wa6C5_tEt5jzR1TjQidT4Gbm-OL_6clnOFRNKJ5QaSx19B3BXkbNMNAbWoHAtZ6qK0WnZ4l56HSyT3lUWXDFZyxA678CoUZ1nlj8nR6lP4QWhbQDLSTRWi8BFo4PWLdOtt5rzpu5UU5BPd7AZN9OJY1WLWwNuBaJsAGWDKBtEuSAf77v_nng0_tbxM8rgvhPSX-cboBRmVgrzL6UoyHuQoLlx2_w8nn_05mZnwElYGeQQBLNGFuTdnYQNfFS4U2JT6PeDATcSN5hBjQuiF6JfjGvZkrY_Mz03Otkwbbcv_8ebvCIPEZopfPA1ORp3-_AGzKCxe5s1Ho5rof8A81ADoQ |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Impact+of+Taurine+on+Obesity-Induced+Diabetes+Mellitus%3A+Mechanisms+Underlying+Its+Effect&rft.jtitle=Endocrinology+and+metabolism+%28Seoul%29&rft.au=Kainat+Ahmed&rft.au=Ha-Neul+Choi&rft.au=Jung-Eun+Yim&rft.date=2023-10-01&rft.pub=Korean+Endocrine+Society&rft.issn=2093-596X&rft.eissn=2093-5978&rft.volume=38&rft.issue=5&rft.spage=482&rft.epage=492&rft_id=info:doi/10.3803%2FEnM.2023.1776&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_508f6d71172646ab98cfba384dc68eb2 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2093-596X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2093-596X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2093-596X&client=summon |